Physician profile
John P Devine
NPI 1376533075
$1,768.91
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $569 · 2020: $443 · 2021: $501 · 2022: $241 · 2023: $15.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $414.82 | 2019-2021 | |
| Pfizer INC. | $178.08 | 2019-2022 | |
| Janssen Biotech, INC. | $172.90 | 2019-2022 | |
| Abbvie INC. | $156.70 | 2019-2021 | |
| Boston Scientific Corporation | $155.59 | 2019-2022 | |
| Travere Therapeutics, INC. | $103.84 | 2019-2022 | |
| Allergan, INC. | $66.84 | 2021-2022 | |
| Urovant Sciences INC | $65.55 | 2021-2022 | |
| Blue Earth Diagnostics | $57.36 | 2019-2020 | |
| Neotract INC. | $50.08 | 2020 | |
| Antares Pharma, INC. | $39.45 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $37.10 | 2021-2022 | |
| 180 Medical, INC. | $33.73 | 2020 | |
| Endo Pharmaceuticals INC. | $32.55 | 2021-2022 | |
| Coloplast Corp | $31.39 | 2021-2023 | Speedicath |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar Pharmaceuticals, INC. | $30.97 | 2020 | |
| Myriad Genetic Laboratories, INC. | $28.58 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $21.93 | 2021 | |
| Bard Access Systems, INC. | $17.28 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $16.94 | 2022 | |
| Cook Medical LLC | $16.08 | 2019 | |
| Rochester Medical Corporation | $16.05 | 2021 | |
| Teleflex LLC | $12.78 | 2021 | |
| Olympus America INC. | $12.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Devine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.